PERTH, Australia – Brisbane, Australia-based Factor Therapeutics Ltd. is stopping all development of VF-001 after a phase II trial in venous leg ulcer healing failed to meet all endpoints, which included reduction in wound size, proportion of patients with ulcers fully healed and time to achieve full wound healing.